What are the diagnostic criteria for polycystic ovary syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

PCOS Diagnosis

Diagnose PCOS in adult women when 2 of 3 Rotterdam criteria are met: (1) androgen excess (clinical or biochemical), (2) ovulatory dysfunction, OR (3) polycystic ovaries on ultrasound—but only after excluding thyroid disease, hyperprolactinemia, and nonclassic congenital adrenal hyperplasia. 1

Diagnostic Criteria for Adults

The Endocrine Society endorses the Rotterdam criteria as the standard diagnostic framework 1:

The Three Cardinal Features (Need 2 of 3):

  1. Androgen Excess

    • Clinical: hirsutism, acne, alopecia, acanthosis nigricans 1
    • Biochemical: elevated serum androgens
    • Can be diagnosed clinically without universal androgen screening if other criteria are met 1
  2. Ovulatory Dysfunction

    • Oligomenorrhea or amenorrhea
    • Screen using menstrual history 1
    • Midluteal progesterone may help confirm anovulation in women with seemingly regular cycles 1
  3. Polycystic Ovaries (PCO)

    • ≥12 follicles measuring 2-9 mm in at least one ovary, OR
    • Ovarian volume >10 mL (without dominant follicle >10 mm) 1
    • Not required if the patient already meets 2 criteria clinically 1

Critical Exclusions (Screen ALL Women):

Mandatory screening tests 1:

  • TSH (exclude thyroid disease)
  • Prolactin (exclude hyperprolactinemia—can present with amenorrhea/hirsutism)
  • 17-hydroxyprogesterone (17-OHP) (exclude nonclassic congenital adrenal hyperplasia, found in 1.5-6.8% of hyperandrogenic women) 1

Additional evaluation for select patients with amenorrhea, virilization, or atypical features 1:

  • Cushing's syndrome (proximal muscle weakness)
  • Acromegaly (frontal bossing)
  • Androgen-secreting tumors

Special Population: Adolescents

In adolescents, require BOTH persistent oligomenorrhea (≥2 years post-menarche) AND hyperandrogenism (clinical or biochemical) for diagnosis. 1

Key Differences from Adult Criteria:

  • Do NOT use polycystic ovarian morphology—normal in pubertal development 1
  • Do NOT use anovulation alone—85% of cycles are anovulatory in year 1 post-menarche, 59% in year 3 1
  • Persistent oligomenorrhea must extend ≥2 years beyond menarche to be diagnostic 1
  • Acne alone is insufficient—common and transitory in adolescence 1
  • Hirsutism is more specific and present in ~60% of adolescent PCOS cases 1

"At Risk" Category:

Adolescents with only ONE feature (either oligomenorrhea OR hyperandrogenism) should be considered "at risk" and require symptom management plus ongoing follow-up 2

Special Population: Perimenopausal/Postmenopausal Women

No established diagnostic criteria exist for this age group. 1

A presumptive diagnosis can be based on:

  • Well-documented history of oligomenorrhea AND hyperandrogenism during reproductive years
  • PCO morphology on ultrasound provides supportive evidence (though less likely present) 1

Common Pitfalls to Avoid:

  1. Over-reliance on ultrasound: If clinical hyperandrogenism and oligomenorrhea are already present, ultrasound adds no diagnostic value 1

  2. Diagnosing adolescents prematurely: Normal pubertal physiology mimics PCOS—irregular cycles are physiologic for years post-menarche 1

  3. Missing exclusion diagnoses: Always screen TSH, prolactin, and 17-OHP before confirming PCOS 1

  4. Using AMH or ultrasound in adolescents: These are not validated for adolescent diagnosis and should be avoided 3, 2

Phenotypic Considerations:

Different combinations of the Rotterdam criteria create distinct phenotypes with varying risk profiles 1:

  • Hyperandrogenism correlates more strongly with metabolic abnormalities
  • Irregular menses + PCO morphology associate more with infertility
  • Document which specific features led to diagnosis for risk stratification

Family History:

PCOS clusters in families with both male and female relatives showing metabolic abnormalities. Take a careful family history and consider screening first-degree relatives. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.